NPS Pharmaceuticals NPSP raised $50 million Monday through the sale of its Preotact royalty stream to Drug Royalty Corporation. We're maintaining our fair value estimate as we believe the exchange was fair but not favorable to shareholders. The proceeds will satisfy part of a $190 million ...
Foreign Takeovers See U.S. Losing Tax Revenue
Biotech Bidding War Yields Rich Price
Research and Markets: Secondary Hyperparathyroidism Pipeline Review 2015 - 6 Companies & 14 Drug Profiles